Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML. [electronic resource]
Producer: 20130212Description: 905-912 p. digitalISSN:- 1552-4469
- Aniline Compounds -- pharmacology
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Benzamides -- pharmacology
- Cell Line, Tumor
- Cell Survival -- drug effects
- Dose-Response Relationship, Drug
- Down-Regulation -- drug effects
- Drug Resistance, Neoplasm -- drug effects
- Drug Synergism
- Fusion Proteins, bcr-abl -- antagonists & inhibitors
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Mice
- Nitriles -- pharmacology
- Piperazines -- pharmacology
- Protein Kinase Inhibitors -- pharmacology
- Proteomics
- Proto-Oncogene Proteins c-myc -- antagonists & inhibitors
- Pyrazoles -- pharmacology
- Pyrimidines -- pharmacology
- Quinolines -- pharmacology
- Structure-Activity Relationship
- Systems Biology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.